LENSTEC, INC.
ST PETERSBURG, FLORIDA

Lenstec, Inc., founded in 1993, stands out as a leading medical device company based in Florida. Known for its strict adherence to international quality standards, Lenstec has earned recognition by consistently producing CE Marked products and fulfilling ISO 13485 requirements. The company's influence spans the global ophthalmic surgical industry with advanced intraocular lenses (IOLs) being utilized in over 60 countries. With headquarters in St. Petersburg, Florida, and operations extending to the United Kingdom alongside a significant 30,000 sq. ft. manufacturing facility in Barbados, Lenstec effectively caters to diverse markets globally. Notably, the company made headlines by securing two U.S. FDA approvals for its Softec implants within just six months in 2010. Lenstec's innovative product lineup includes standout offerings such as the precise Softec HD family monofocal IOLs, the SBL-3 Segmented Bifocal Lens enhancing vision with superior contrast sensitivity, and the post-refractive Softec Aspheric Posterior Chamber Intraocular Lens tailored for patients undergoing phacoemulsification. These developments underscore Lenstec's dedication to pushing the boundaries of ophthalmic surgery techniques. At the helm is CEO John Clough, with support from Secretary Jennifer Gee, Lenstec continues its pursuit of innovative eye care solutions. The company holds prominent trademarks including Softec, Tetraflex, and SBL-3. To learn more about their product offerings or additional corporate information, you can visit lenstec.com.